Customization: | Available |
---|---|
Varieties: | General Disease Prevention Medicine |
Component: | Chemical Synthetic Drugs |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Cefquinome Sulfate Injection |
Composition (per gram) |
Cefquinome Sulfate |
Character | This product is a suspension oil solution with fine particles. After standing, the fine particles sink and shake well into a uniform white to pale brown suspension. |
Indications | Aminoglycoside antibiotic. Used for the treatment of septicaemia and infections of the urogenital tract and respiratory tracts, also for porcine asthma. |
Dosage and Administration | Intramuscular injection: a single dose of 0.1-0.15ml per 1kg body weight for domestic animals. 2 times a day ,3-5 days consecutive days. |
Cautions |
1.Animals allergic to β -lactam antibiotics are prohibited.
2.Those who are allergic to penicillin and cephalosporin antibiotics should not contact this product.
3.It should be fully shaken well before use. |
Withdrawal period | Pig 72 hours. |
Adverse reactions | According to the prescribed dose, no adverse reactions. |
Storage | Closed, stored in cool places. |
Drug interaction | Pharmacodynamics:Cefoquine oxime is the fourth generation of cephalosporin antibiotic. It achieves a bactericidal effect by inhibiting the synthesis of cell walls, with broad-spectrum antimicrobial activity and stabilization against β -lactamase. In vitro bacteriostatic tests showed that cefoxixime was susceptible to common Gram-positive and Gram-negative bacteria, including Escherichia coli, Citrobacter, Klebsiella, Pasterella, Proteus, Salmonella, Serratia marcescens, Haemophilus bovis, Actina pyogenes, bacteria, Corynebacterium, Bacillus, Staphylococcus aureus, Streptococcus, Bacteroids, Clostridium, Fusobacterium, Prevotella, Actinobacillus, and Dantanonas salcis. Pharmacokinetics:The intramuscular injection of cefquixime 2mg per 1kg body weight reached a peak blood concentration after 0.4 hours with a peak concentration of 5.93 μg/ml, an elimination half-life of about 1.4 hours and the area under the curve of 12.34 μ gh / ml. |